Skip to main content

Fresh Tracks Therapeutics, Inc.

FRTXDelisted Dec 27, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000819050

Fresh Tracks Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Jun 11, 2024; 15 institutions reported holding it in 13F filings for Q3 2023, worth $455.8K in total; no superinvestor held it.

13F holders, Q4 2023

Institutional positions in Fresh Tracks Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

FRTX is no longer listed, and 13F filings after Q3 2023 list far fewer holders. See Q3 2023

Institutional holders
1
−14 vs. Q3 2023
Shares held
916
−469.1K (−99.8%) vs. Q3 2023
Total value
$1.00K
−$454.8K (−99.8%) vs. Q3 2023
New holders
0
0 more added
Sold out
14
0 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 1 institution
Q1 2021: 32 institutionsQ2 2021: 35 institutionsQ3 2021: 30 institutionsQ4 2021: 34 institutionsQ1 2022: 25 institutionsQ2 2022: 25 institutionsQ3 2022: 17 institutionsQ4 2022: 16 institutionsQ1 2023: 18 institutionsQ2 2023: 15 institutionsQ3 2023: 15 institutionsQ4 2023: 1 institutionQ1 2024: 1 institutionQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2023: $1.00K
Q1 2021: $6.08MQ2 2021: $7.15MQ3 2021: $5.53MQ4 2021: $2.69MQ1 2022: $2.44MQ2 2022: $898.9KQ3 2022: $328.0KQ4 2022: $224.1KQ1 2023: $97.3KQ2 2023: $69.8KQ3 2023: $455.8KQ4 2023: $1.00KQ1 2024: $40Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding FRTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20241$40
Q4 20231$1.00K
Q3 202315$455.8K
Q2 202315$69.8K
Q1 202318$97.3K
Q4 202216$224.1K
Q3 202217$328.0K
Q2 202225$898.9K
Q1 202225$2.44M
Q4 202134$2.69M
Q3 202130$5.53M
Q2 202135$7.15M
Q1 202132$6.08M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Fresh Tracks Therapeutics, Inc.; share changes are against Q3 2023.

Institutions holding FRTX in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Ronald Blue Trust, Inc.916$1.00K0.00%00.0%Unchanged
JBF Capital, Inc.0$00.00%−295,000−100.0%Sold out
GTS Securities LLC0$00.00%−50,100−100.0%Sold out
Virtu Financial LLC0$00.00%−43,558−100.0%Sold out
Geode Capital Management, LLC0$00.00%−41,449−100.0%Sold out
Vanguard Group Inc0$00.00%−23,060−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−10,224−100.0%Sold out
BlackRock Inc.0$00.00%−4,790−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−709−100.0%Sold out
Wells Fargo & Company0$00.00%−154−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−43−100.0%Sold out
JFS Wealth Advisors, LLC0$00.00%−22−100.0%Sold out
FMR LLC0$00.00%−13−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−11−100.0%Sold out
Royal Bank of Canada0$00.00%−6−100.0%Sold out